ArticleBiomedicines2025

Mutations in CREBBP and EP300 HAT and Bromo Domains Drive Hypermutation and Predict Survival in GI Cancers Treated with Immunotherapy.

Mariia Gusakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.